news & resources

in the news

JANSSEN DEAL GIVES NEW KID IN TOWN PROVENTION TWO IMMUNE CANDIDATES

SEPTEMBER 21, 2017
________________

PROVENTION DETAILS PIPELINE

SEPTEMBER 21, 2017
________________

PROVENTION BIO TO DEVELOP TWO JANSSEN GI IMMUNOLOGY CANDIDATES

SEPTEMBER 21, 2017
________________

PROVENTION BIO ANNOUNCES LICENSING AGREEMENTS WITH JANSSEN FOR TWO CLINICAL-STAGE IMMUNOLOGY ASSETS

SEPTEMBER 21, 2017
________________

WITH HELP FROM J&J, UPSTART PROVENTION LANDS RIGHTS TO TWO MID-STAGE IBD DRUGS AND SHOOTS FOR PHII

SEPTEMBER 21, 2017
________________

PRIVATE EQUITY-LIKE FUND AIMS TO SPEED UP DIABETES RESEARCH

JULY 28, 2017
________________

PROVENTION BIO WANTS TO STOP TYPE I DIABETES – WITH A VACCINE

JULY 25, 2017
________________

PROVENTION BIO EVALUATES VACCINE TO PREVENT ONSET OF T1D

JULY 18, 2017
________________

BIOPHARMA COMPANY ADDS VETERAN CHIEF MEDICAL OFFICER

JULY 11, 2017
________________

PROVENTION RAISES $28.4M IN SERIES A

JUNE 27, 2017
________________

LANGER-INSPIRED KALA FILES FOR AN $86M IPO; J&J BACKS PROVENTION BIO A

JUNE 26, 2017
________________

PROVENTION BIO RAKES IN $28.4 MLN SERIES A

JUNE 26, 2017
________________

PROVENTION LANDS $28.4M FINANCING TO ADVANCE ASSETS FROM JANSSEN, FINLAND’S VACTECH (SUBSCRIPTION REQUIRED)

JUNE 26, 2017